Financial reports
20-F
2018 FY
Annual report (foreign)
14 Sep 18
NT 20-F
Notice of late annual filing (foreign)
31 Aug 18
20-F/A
2017 FY
Annual report (foreign) (amended)
11 Apr 18
20-F/A
2017 FY
Annual report (foreign) (amended)
31 Oct 17
20-F
2017 FY
Annual report (foreign)
24 Aug 17
20-F
2016 FY
Annual report (foreign)
26 Aug 16
Current reports
6-K
Nomination committee in Oasmia for the 2019 AGM
21 Aug 19
6-K
Oasmia postpones the release of the Q1 report to 26 September and adjusts its financial calendar
15 Aug 19
6-K
Oasmia intends to delist from NASDAQ in the US to reduce complexity and costs
6 Aug 19
6-K
Current report (foreign)
1 Aug 19
6-K
Current report (foreign)
9 Jul 19
6-K
Oasmia appoints Business Advisory Board
9 Jul 19
6-K
Oasmia appoints new CMO
2 Jul 19
6-K
Events In Fourth Quarter
28 Jun 19
6-K
Oasmia presents full-year report and status in the Board's review through audiocast on June 28
26 Jun 19
6-K
Current report (foreign)
25 Jun 19
Registration and prospectus
424B3
Prospectus supplement
4 Apr 22
424B3
Prospectus supplement
27 Nov 19
F-6 POS
Automatic registration for ADRs (post-effective amendment, foreign)
21 Nov 19
424B3
Prospectus supplement
23 Aug 19
15F-12B
Securities registration termination (foreign)
23 Aug 19
25
Voluntary exchange delisting
13 Aug 19
POS AM
Prospectus update (post-effective amendment)
8 Aug 19
F-3/A
Shelf registration (foreign) (amended)
18 May 18
F-3
Shelf registration (foreign)
30 Apr 18
POS AM
Prospectus update (post-effective amendment)
2 Aug 17
Proxies
No filings
Other
EFFECT
Notice of effectiveness
13 Aug 19
EFFECT
Notice of effectiveness
25 May 18
CORRESP
Correspondence with SEC
22 May 18
UPLOAD
Letter from SEC
14 May 18
UPLOAD
Letter from SEC
3 May 18
CT ORDER
Confidential treatment order
1 Nov 17
EFFECT
Notice of effectiveness
7 Aug 17
EFFECT
Notice of effectiveness
2 Aug 16
CT ORDER
Confidential treatment order
27 Oct 15
EFFECT
Notice of effectiveness
22 Oct 15